IL15 and neoplasm: An additional possibility is that excised tumors of patients could be confronted with ex vivo–expanded autologous NK cells and exogenous cytokines IL-15, IL-18, IL-22, and IL-23 to reactivate the immune response and establish specific tumor recognition.